Search

everythinglearnresearchcommunity

for

Search:↓

The 15th Jornada de Dermatología was a successful dermatology event with international experts discussing various topics.

Both rosemary extract and 2% ketoconazole lotions effectively treat seborrheic dermatitis and improve quality of life.

Ultrasonic and infrared treatments can improve hair strength and appearance with minimal damage.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Sunscreen use may increase the risk of frontal fibrosing alopecia.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Anthralin cream helped 25% of patients with severe alopecia areata regrow hair, but caused skin irritation.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Monoclonal antibodies are often linked to alopecia areata cases.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.